Literature DB >> 31818963

Caspase-4 Mediates Restriction of Burkholderia pseudomallei in Human Alveolar Epithelial Cells.

Chanya Srisaowakarn1, Matsayapan Pudla2, Marisa Ponpuak1, Pongsak Utaisincharoen3.   

Abstract

Melioidosis is an infectious disease with a high mortality rate responsible for community-acquired sepsis in Southeast Asia and Northern Australia. The causative agent of this disease is Burkholderia pseudomallei, a Gram-negative bacterium that resides in soil and contaminated natural water. After entering into host cells, the bacteria escape into the cytoplasm, which has numerous cytosolic sensors, including the noncanonical inflammatory caspases. Although the noncanonical inflammasome (caspase-11) has been investigated in a murine model of B. pseudomallei infection, its role in humans, particularly in lung epithelial cells, remains unknown. We, therefore, investigated the function of caspase-4 (ortholog of murine caspase-11) in intracellular killing of B. pseudomallei The results showed that B. pseudomallei induced caspase-4 activation at 12 h postinfection in human alveolar epithelial A549 cells. The number of intracellular B. pseudomallei bacteria was increased in the absence of caspase-4, suggesting its function in intracellular bacterial restriction. In contrast, a high level of caspase-4 processing was observed when cells were infected with lipopolysaccharide (LPS) mutant B. pseudomallei The enhanced bacterial clearance in LPS-mutant-infected cells is also correlated with a higher degree of caspase-4 activation. These results highlight the susceptibility of the LPS mutant to caspase-4-mediated intracellular bacterial killing.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Burkholderia pseudomalleizzm321990; caspase-4; human lung epithelial cell (A549); melioidosis; noncanonical inflammasome

Mesh:

Substances:

Year:  2020        PMID: 31818963      PMCID: PMC7035936          DOI: 10.1128/IAI.00868-19

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Involvement of the MyD88-independent pathway in controlling the intracellular fate of Burkholderia pseudomallei infection in the mouse macrophage cell line RAW 264.7.

Authors:  S Tangsudjai; M Pudla; K Limposuwan; D E Woods; S Sirisinha; P Utaisincharoen
Journal:  Microbiol Immunol       Date:  2010-05       Impact factor: 1.955

2.  Role of Burkholderia pseudomallei in the invasion, replication and induction of apoptosis in human epithelial cell lines.

Authors:  Arunya Phewkliang; Surasak Wongratanacheewin; Sorujsiri Chareonsudjai
Journal:  Southeast Asian J Trop Med Public Health       Date:  2010-09       Impact factor: 0.267

3.  Noncanonical inflammasome activation of caspase-4/caspase-11 mediates epithelial defenses against enteric bacterial pathogens.

Authors:  Leigh A Knodler; Shauna M Crowley; Ho Pan Sham; Hyungjun Yang; Marie Wrande; Caixia Ma; Robert K Ernst; Olivia Steele-Mortimer; Jean Celli; Bruce A Vallance
Journal:  Cell Host Microbe       Date:  2014-08-13       Impact factor: 21.023

4.  Human {beta}-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells.

Authors:  Bruno Rivas-Santiago; Stephan K Schwander; Carmen Sarabia; Gill Diamond; Marcia E Klein-Patel; Rogelio Hernandez-Pando; Jerrold J Ellner; Eduardo Sada
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Human caspase-4 mediates noncanonical inflammasome activation against gram-negative bacterial pathogens.

Authors:  Cierra N Casson; Janet Yu; Valeria M Reyes; Frances O Taschuk; Anjana Yadav; Alan M Copenhaver; Hieu T Nguyen; Ronald G Collman; Sunny Shin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-11       Impact factor: 11.205

6.  The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence.

Authors:  D DeShazer; P J Brett; D E Woods
Journal:  Mol Microbiol       Date:  1998-12       Impact factor: 3.501

7.  The Shigella OspC3 effector inhibits caspase-4, antagonizes inflammatory cell death, and promotes epithelial infection.

Authors:  Taira Kobayashi; Michinaga Ogawa; Takahito Sanada; Hitomi Mimuro; Minsoo Kim; Hiroshi Ashida; Reiko Akakura; Mitsutaka Yoshida; Magdalena Kawalec; Jean-Marc Reichhart; Tsunehiro Mizushima; Chihiro Sasakawa
Journal:  Cell Host Microbe       Date:  2013-05-15       Impact factor: 21.023

8.  Virulent Burkholderia pseudomallei is more efficient than avirulent Burkholderia thailandensis in invasion of and adherence to cultured human epithelial cells.

Authors:  Wannapa Kespichayawattana; Pakamas Intachote; Pongsak Utaisincharoen; Stitaya Sirisinha
Journal:  Microb Pathog       Date:  2004-05       Impact factor: 3.738

9.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta.

Authors:  Fabio Martinon; Kimberly Burns; Jürg Tschopp
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

10.  Human caspase-4 detects tetra-acylated LPS and cytosolic Francisella and functions differently from murine caspase-11.

Authors:  Brice Lagrange; Sacha Benaoudia; Pierre Wallet; Flora Magnotti; Angelina Provost; Fanny Michal; Amandine Martin; Flaviana Di Lorenzo; Bénédicte F Py; Antonio Molinaro; Thomas Henry
Journal:  Nat Commun       Date:  2018-01-16       Impact factor: 14.919

View more
  3 in total

Review 1.  Mechanisms and Consequences of Noncanonical Inflammasome-Mediated Pyroptosis.

Authors:  Skylar S Wright; Swathy O Vasudevan; Vijay A Rathinam
Journal:  J Mol Biol       Date:  2021-09-16       Impact factor: 5.469

2.  IGF2BP2 knockdown inhibits LPS-induced pyroptosis in BEAS-2B cells by targeting caspase 4, a crucial molecule of the non-canonical pyroptosis pathway.

Authors:  Jing Wang; Xiaoli Yuan; Ning Ding
Journal:  Exp Ther Med       Date:  2021-04-08       Impact factor: 2.447

3.  Increased platelet activation and platelet-inflammasome engagement during chikungunya infection.

Authors:  Isaclaudia Gomes de Azevedo-Quintanilha; Mariana Macedo Campos; Ana Paula Teixeira Monteiro; Alessandra Dantas do Nascimento; Andrea Surrage Calheiros; Douglas Mathias Oliveira; Suelen Silva Gomes Dias; Vinicius Cardoso Soares; Julia da Cunha Santos; Isabel Tavares; Thiago Moreno Lopes Souza; Eugenio D Hottz; Fernando A Bozza; Patricia T Bozza
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.